FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Lee, Hyung Ok ^a   Mullins, Stefanie R ^a   Franco Barraza, Janusz ^a   Valianou, Matthildi ^a   Cukierman, Edna ^a   Cheng, Jonathan D ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; COLLAGEN FIBER; FIBROBLAST ACTIVATION PROTEIN; FIBRONECTIN; FOCAL ADHESION KINASE; REGULATOR PROTEIN; SERINE PROTEINASE; TETRACYCLINE; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; FOCAL ADHESION KINASE 1; GELATINASE; HYBRID PROTEIN; MEMBRANE PROTEIN; PTK2 PROTEIN, HUMAN; SCLEROPROTEIN; SEPRASE; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PANCREAS CANCER; PHENOTYPE; SIGNAL TRANSDUCTION; STROMA; TIME LAPSE IMAGING; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; BREAST TUMOR; CELL MOTION; CELL STRAIN 3T3; CULTURE TECHNIQUE; ENZYMOLOGY; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE MUTANT; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD29; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; FOCAL ADHESION KINASE 1; GELATINASES; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NIH 3T3 CELLS; PANCREATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; SERINE ENDOPEPTIDASES; TIME-LAPSE IMAGING; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT;

EID: 79958250916     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-245     Document Type: Article

References (49)

1. Kiaris H, Chatzistamou I, Kalofoutis C, Koutselini H, Piperi C, Kalofoutis A. Tumour-stroma interactions in carcinogenesis: basic aspects and perspectives. Mol Cell Biochem 2004, 261(1-2):117-122.
2. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EW, de la Chapelle A, Frankel WL. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004, 23(44):7366-7377. 10.1038/sj.onc.1208013, 15326482.
3. Ruiter D, Bogenrieder T, Elder D, Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol 2002, 3(1):35-43. 10.1016/S1470-2045(01)00620-9, 11905603.
4. Sato N, Maehara N, Goggins M. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res 2004, 64(19):6950-6956. 10.1158/0008-5472.CAN-04-0677, 15466186.
5. Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr Opin Genet Dev 2009, 19(1):67-73. 10.1016/j.gde.2009.01.003, 19211240.
6. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007, 101(4):805-815. 10.1002/jcb.21159, 17226777.
7. Mahadevan D, Von Hoff DD. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 2007, 6(4):1186-1197. 10.1158/1535-7163.MCT-06-0686, 17406031.
8. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002, 70(9-10):486-497. 10.1046/j.1432-0436.2002.700903.x, 12492491.
9. Edwards DR, Murphy G. Cancer. Proteases--invasion and more. Nature 1998, 394(6693):527-528. 10.1038/28961, 9707109.
10. Johnsen M, Lund LR, Romer J, Almholt K, Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998, 10(5):667-671. 10.1016/S0955-0674(98)80044-6, 9818179.
11. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6(5):392-401. 10.1038/nrc1877, 16572188.
12. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 1999, 274(51):36505-36512. 10.1074/jbc.274.51.36505, 10593948.
13. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, Chen WT. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 1994, 54(21):5702-5710.
14. Mueller SC, Ghersi G, Akiyama SK, Sang QX, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y, Chen WT. A novel protease-docking function of integrin at invadopodia. J Biol Chem 1999, 274(35):24947-24952. 10.1074/jbc.274.35.24947, 10455171.
15. Wang XM, Yu DM, McCaughan GW, Gorrell MD. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology 2005, 42(4):935-945. 10.1002/hep.20853, 16175601.
16. Cheng JD, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res 2002, 62(16):4767-4772.
17. Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Mol Cancer Ther 2005, 4(3):351-360.
18. Cohen SJ, Alpaugh RK, Palazzo I, Meropol NJ, Rogatko A, Xu Z, Hoffman JP, Weiner LM, Cheng JD. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 2008, 37(2):154-158. 10.1097/MPA.0b013e31816618ce, 18665076.
19. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003, 15(6):753-762. 10.1016/j.ceb.2003.10.016, 2933200, 14644202.
20. Grzesiak JJ, Ho JC, Moossa AR, Bouvet M. The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 2007, 35(4):293-301. 10.1097/mpa.0b013e31811f4526, 18090233.
21. Amatangelo MD, Bassi DE, Klein-Szanto AJ, Cukierman E. Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts. Am J Pathol 2005, 167(2):475-488. 10.1016/S0002-9440(10)62991-4, 1603576, 16049333.
22. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 2006, 4(1):38. 10.1186/1741-7015-4-38, 1781458, 17190588.
23. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139(5):891-906. 10.1016/j.cell.2009.10.027, 2788004, 19931152.
24. Miura N, Kanayama Y, Nagai W, Hasegawa T, Seko Y, Kaji T, Naganuma A. Characterization of an immortalized hepatic stellate cell line established from metallothionein-null mice. J Toxicol Sci 2006, 31(4):391-398. 10.2131/jts.31.391, 17077592.
25. Castello-Cros R, Cukierman E. Stromagenesis during tumorigenesis: characterization of tumor-associated fibroblasts and stroma-derived 3D matrices. Methods Mol Biol 2009, 522:275-305. 10.1007/978-1-59745-413-1_19, 2670062, 19247611.
26. Cukierman E. A visual-quantitative analysis of fibroblastic stromagenesis in breast cancer progression. J Mammary Gland Biol Neoplasia 2004, 9(4):311-324. 10.1007/s10911-004-1403-y, 15838602.
27. Cukierman E. Cell migration analyses within fibroblast-derived 3-D matrices. Cell migration: Developmental methods and protocols 2005, 294:79-93. Totowa NJ: Humana Press, Guan J.
28. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 2001, 294(5547):1708-1712. 10.1126/science.1064829, 11721053.
29. Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, Matsumoto K, Yamada KM. A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 2005, 170(5):793-802. 10.1083/jcb.200503152, 2171343, 16129786.
30. Goodman JD, Rozypal TL, Kelly T. Seprase, a membrane-bound protease, alleviates the serum growth requirement of human breast cancer cells. Clin Exp Metastasis 2003, 20(5):459-470. 10.1023/A:1025493605850, 14524536.
31. Jin X, Iwasa S, Okada K, Mitsumata M, Ooi A. Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. Anticancer Res 2003, 23(4):3195-3198.
32. Iwasa S, Jin X, Okada K, Mitsumata M, Ooi A. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett 2003, 199(1):91-98. 10.1016/S0304-3835(03)00315-X, 12963128.
33. Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer 2001, 95(1):67-72. 10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U, 11241314.
34. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 1994, 91(12):5657-5661. 10.1073/pnas.91.12.5657, 44055, 7911242.
35. Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 2007, 13(6):1736-1741. 10.1158/1078-0432.CCR-06-1746, 17363526.
36. Niedermeyer J, Scanlan MJ, Garin-Chesa P, Daiber C, Fiebig HH, Old LJ, Rettig WJ, Schnapp A. Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int J Cancer 1997, 71(3):383-389. 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H, 9139873.
37. Castello-Cros R, Khan DR, Simons J, Valianou M, Cukierman E. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins. BMC Cancer 2009, 9:94. 10.1186/1471-2407-9-94, 2669806, 19323811.
38. Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Muller E, Rettig WJ, Gorrell MD. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 1999, 29(6):1768-1778. 10.1002/hep.510290631, 10347120.
39. Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007, 117(1):50-59. 10.1172/JCI30082, 1716214, 17200706.
40. Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR, Johnson CD, Benyon RC, Iredale JP. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res 2004, 10(21):7427-7437. 10.1158/1078-0432.CCR-03-0825, 15534120.
41. Loukopoulos P, Kanetaka K, Takamura M, Shibata T, Sakamoto M, Hirohashi S. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity. Pancreas 2004, 29(3):193-203. 10.1097/00006676-200410000-00004, 15367885.
42. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, et al. Differential regulation of cell motility and invasion by FAK. J Cell Biol 2003, 160(5):753-767. 10.1083/jcb.200212114, 2173366, 12615911.
43. Quiros RM, Valianou M, Kwon Y, Brown KM, Godwin AK, Cukierman E. Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. Gynecol Oncol 2008, 110(1):99-109. 10.1016/j.ygyno.2008.03.006, 2612536, 18448156.
44. Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 2005, 15(5):329-341. 10.1016/j.semcancer.2005.05.003, 15970443.
45. Santos A, Jung J, Aziz N, Kissil JL, Puré E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. The Journal of Clinical Investigation 2009, 119(12):3613-3625. 10.1172/JCI38988, 2786791, 19920354.
46. Farrow B, Rowley D, Dang T, Berger DH. Characterization of Tumor-Derived Pancreatic Stellate Cells. J Surg Res 2009, 157(1):96-102.
47. Mersmann M, Schmidt A, Rippmann JF, Wuest T, Brocks B, Rettig WJ, Garin-Chesa P, Pfizenmaier K, Moosmayer D. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. Int J Cancer 2001, 92(2):240-248. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1170>3.0.CO;2-U, 11291052.
48. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003, 3(12):921-930. 10.1038/nrc1231, 14737122.
49. Binkley CE, Zhang L, Greenson JK, Giordano TJ, Kuick R, Misek D, Hanash S, Logsdon CD, Simeone DM. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas 2004, 29(4):254-263. 10.1097/00006676-200411000-00003, 15502640.